Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5072549 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL5072438 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL29967496 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1865691 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL5070157 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL38296 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL2238894 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL5072514 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL22116424 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1812050 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 725 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119654316-A | Thioglutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119451952-A | Oxo-isoindolinyl substituted tetrahydropyrimidinedione derivative and application thereof | 标新生物医药科技(上海)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118556047-A | Oxo-isoindolinyl substituted piperidinedione derivative and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118556048-A | Sulfur/oxygen substituted glutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| US-20240101552-A1 | CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2024-03-28 | — | — | US | claimed |
| US-20240092815-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | claimed |
| WO-2024044486-A1 | JAK2 INHIBITOR COMPOUNDS | AJAX THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | claimed |
| CN-117126151-A | Glycolate oxidase inhibitors for use in the treatment of disease | 生物马林药物股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-117069712-A | Glycolate oxidase inhibitors for use in the treatment of disease | 生物马林药物股份有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-117069713-A | Glycolate oxidase inhibitors for use in the treatment of disease | 生物马林药物股份有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-114401972-A | Photochromic compound and curable composition containing same | 株式会社德山 | 2022-04-26 | — | — | CN | claimed |
| US-11254108-B2 | Laminate structure for biocompatible barrier packaging | RENOLIT SE (DE) | 2022-02-22 | — | — | US | claimed |
| CN-111989382-A | Photochromic compound, curable composition containing same, and optical article | 株式会社德山 | 2020-11-24 | — | — | CN | claimed |
| CN-110869355-A | Benzopyran compound, curable composition containing benzopyran compound, and optical article containing cured product formed from curable composition | 株式会社德山 | 2020-03-06 | — | — | CN | claimed |
| US-20110034628-A1 | BRANCHED POLYOLS CONTAINING ON AVERAGE TWO OR MORE HYDROXYL GROUPS PER MOLECULE,THEIR PREPARATION AND USE | BASF COATINGS AG (DE) | 2011-02-10 | — | — | US | claimed |
| EP-2027174-A1 | BRANCHED POLYOLS HAVING A STATISTICAL AVERAGE OF TWO OR MORE HYDROXYL GROUPS IN THE MOLECULE, PROCESS FOR THEIR PREPARATION AND USE THEREOF | BASF Coatings AG (DE) | 2009-02-25 | — | — | EP | claimed |
| WO-2007131674-A1 | BRANCHED POLYOLS HAVING A STATISTICAL AVERAGE OF TWO OR MORE HYDROXYL GROUPS IN THE MOLECULE, PROCESS FOR THEIR PREPARATION AND USE THEREOF | BASF COATINGS AG (DE) | 2007-11-22 | — | — | WO | claimed |
| US-5411982-A | Cycloalkylene azoles, and their use as aromatase inhibitors | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-05-02 | — | — | US | claimed |
| US-5280035-A | Cycloalkylene azoles and their use as aromatase inhibitors | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-01-18 | — | — | US | claimed |
| US-5135937-A | Aromatase inhibitors | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-08-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101552-A1 | CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | LANCL2, CBS, LCP2 | ALDH1A1 3956/4885 |
| US-20240092815-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, GPX1, CRY1 | ALDH1A1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.